120 related articles for article (PubMed ID: 37121540)
61. Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet.
Prasomthong J; Limpeanchob N; Daodee S; Chonpathompikunlert P; Tunsophon S
Sci Rep; 2022 Apr; 12(1):7022. PubMed ID: 35487948
[TBL] [Abstract][Full Text] [Related]
62. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation.
Li H; Ying H; Hu A; Hu Y; Li D
Biol Pharm Bull; 2017; 40(5):650-657. PubMed ID: 28458350
[TBL] [Abstract][Full Text] [Related]
63. Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model.
Zhu CG; Liu YX; Wang H; Wang BP; Qu HQ; Wang BL; Zhu M
Endocr J; 2017 Jul; 64(7):663-673. PubMed ID: 28539530
[TBL] [Abstract][Full Text] [Related]
64. Pathophysiology of high fat diet induced obesity: impact of probiotic banana juice on obesity associated complications and hepatosteatosis.
Konda PY; Poondla V; Jaiswal KK; Dasari S; Uyyala R; Surtineni VP; Egi JY; Masilamani AJA; Bestha L; Konanki S; Muthulingam M; Lingamgunta LK; Aloor BP; Tirumalaraju S; Sade A; Ratnam Kamsala V; Nagaraja S; Ramakrishnan R; Natesan V
Sci Rep; 2020 Oct; 10(1):16894. PubMed ID: 33037249
[TBL] [Abstract][Full Text] [Related]
65. Role of liquid fructose/sucrose in regulating the hepatic transcriptome in a high-fat Western diet model of NAFLD.
Luo Y; Woodie LN; Graff EC; Zhang J; Fowler S; Wang X; Wang X; O'Neill AM; Greene MW
J Nutr Biochem; 2023 Feb; 112():109174. PubMed ID: 36280127
[TBL] [Abstract][Full Text] [Related]
66. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
67. Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD).
Elvira-Torales LI; Periago MJ; González-Barrio R; Hidalgo N; Navarro-González I; Gómez-Gallego C; Masuero D; Soini E; Vrhovsek U; García-Alonso FJ
Food Funct; 2019 Apr; 10(4):2148-2160. PubMed ID: 30938723
[TBL] [Abstract][Full Text] [Related]
68. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling.
Softic S; Gupta MK; Wang GX; Fujisaka S; O'Neill BT; Rao TN; Willoughby J; Harbison C; Fitzgerald K; Ilkayeva O; Newgard CB; Cohen DE; Kahn CR
J Clin Invest; 2017 Nov; 127(11):4059-4074. PubMed ID: 28972537
[TBL] [Abstract][Full Text] [Related]
69. The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
Cheng K; Song Z; Zhang H; Li S; Wang C; Zhang L; Wang T
Med Mol Morphol; 2019 Dec; 52(4):187-197. PubMed ID: 30673851
[TBL] [Abstract][Full Text] [Related]
70. The potential of antioxidant-rich Maoberry (Antidesma bunius) extract on fat metabolism in liver tissues of rats fed a high-fat diet.
Ngamlerst C; Udomkasemsab A; Kongkachuichai R; Kwanbunjan K; Chupeerach C; Prangthip P
BMC Complement Altern Med; 2019 Nov; 19(1):294. PubMed ID: 31684925
[TBL] [Abstract][Full Text] [Related]
71. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
72. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
73. Dietary Glycotoxins Impair Hepatic Lipidemic Profile in Diet-Induced Obese Rats Causing Hepatic Oxidative Stress and Insulin Resistance.
Neves C; Rodrigues T; Sereno J; Simões C; Castelhano J; Gonçalves J; Bento G; Gonçalves S; Seiça R; Domingues MR; Castelo-Branco M; Matafome P
Oxid Med Cell Longev; 2019; 2019():6362910. PubMed ID: 31341532
[TBL] [Abstract][Full Text] [Related]
74. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
[TBL] [Abstract][Full Text] [Related]
75. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling.
Kim MH; Seong JB; Huh JW; Bae YC; Lee HS; Lee DS
Redox Biol; 2020 Jan; 28():101315. PubMed ID: 31505325
[TBL] [Abstract][Full Text] [Related]
76. Short-term strength training reduces gluconeogenesis and NAFLD in obese mice.
Pereira RM; Rodrigues KCDC; Anaruma CP; Sant'Ana MR; de Campos TDP; Gaspar RS; Canciglieri RDS; de Melo DG; Mekary RA; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
J Endocrinol; 2019 Apr; 241(1):59-70. PubMed ID: 30878016
[TBL] [Abstract][Full Text] [Related]
77. Sugary Kefir Strain Lactobacillus mali APS1 Ameliorated Hepatic Steatosis by Regulation of SIRT-1/Nrf-2 and Gut Microbiota in Rats.
Chen YT; Lin YC; Lin JS; Yang NS; Chen MJ
Mol Nutr Food Res; 2018 Apr; 62(8):e1700903. PubMed ID: 29508520
[TBL] [Abstract][Full Text] [Related]
78. Modulation of hepatic steatosis by dietary fatty acids.
Ferramosca A; Zara V
World J Gastroenterol; 2014 Feb; 20(7):1746-55. PubMed ID: 24587652
[TBL] [Abstract][Full Text] [Related]
79. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
80. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
